Organoidsciences Ltd. (KOSDAQ:476040)
South Korea flag South Korea · Delayed Price · Currency is KRW
30,450
+600 (2.01%)
At close: Aug 4, 2025, 3:30 PM KST

Organoidsciences Company Description

Organoidsciences Ltd. develops regenerative therapies in South Korea.

It develops ATORM, an adult tissue derived organoid based regenerative medicine platform for the treatment of intractable intestinal ulcers, as well as salivary glands, liver, and uterus disease areas; ODISEI solutions, an organoid-based discovery platform for screening evaluation and identification; and EXPANSION, an organoid-based advanced science for innovative solutions.

The company was founded in 2018 and is based in Seongnam-si, South Korea.

Organoidsciences Ltd.
CountrySouth Korea
Founded2018
IndustryPharmaceutical Preparations
CEOJong-Man Yoo

Contact Details

Address:
338 Pangyo-ro
Seongnam-si, 13488
South Korea
Phone82 2 707 2024
Websiteorganoidrx.com

Stock Details

Ticker Symbol476040
ExchangeKOSDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyKRW
SIC Code2834

Key Executives

NamePosition
Jong-Man YooChief Executive Officer